TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Élisabeth Quoix, H. Léna, György Losonczy, Frédéric Forget, C. Chouaïd, Zsolt Pápai, Radj Gervais, Christian H. Ottensmeier, Aleksandra Szczęsna, Andrzej Każarnowicz,

The Lancet Oncology · 2015 · 207 citations · 16 references

Concepts

References

16